Clinical Trial Update: The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines [Phase 4]

View source ↗

Summary

Phase 4 trial assessing immunogenicity and safety of inactivated and live attenuated Hepatitis A vaccines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Hepatitis A vaccine (inactivated) (inactivated Hepatitis A vaccine)
• Hepatitis A vaccine (live attenuated) (Hepatitis A vaccine)

Snippet

Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences | Conditions: Hepatitis A | Phase 4 | Status: COMPLETED